News

Part 3 of the PraxisUnico Conference podcasts, Malcolm Skingle and other speakers including Robert Sorrell speaks about "Innovating Exploitation Models"

11 proposals will be brought into effect, as detailed in the response document.

The first of our Conference podcasts is now available, sponsored by Forresters.

Hot off the presses, our conference newsletter.

Mercia Fund Management has followed up on its first investment in 2015 with follow-on capital to Medherant Ltd. A total of £250,000 from both Mercia’s third-party University Growth Fund and Growth Fund 4 will allow Medherant to continue product development. Medherant has moved to new laboratories, and KEC professional Andrew Lee has been seconded from Warwick Ventures to the project.

Dr Emma Elliott RTTP was the successful applicant for the Inteum sponsored scholarship to attend this year's PraxisUnico Conference

Since 2009, Innovation Prize awards the most innovative startups (<8 years old) and the best research academic groups that are developing cutting edge technologies in the field of life sciences (Biotech, Medtech, m/e-health, diagnostics). The Innovation Prize of Universal Biotech aims to promote on an international scale the most innovative projects in the field of Life Sciences. The awarding ceremony will be held at the Innovation Days 2016, a networking BtoB event which will take place at the Maison de la Chimie in Paris, on October the 3rd & the 4th.

Apollo Therapeutics, the investment fund focused on driving therapeutic innovation through university collaboration, has appointed Dr Richard Butt as CEO, effective from 23 May 2016.

PraxisUnico members can join the Network for the Assessment & Evaluation of the Societal Impact of Science (AESIS) Network free of charge and benefit from additional discounts and services

NCUB have completed a new survey of over 18,000 academics in the UK looking at the changing state of Knowledge Exchange. The report looks at academic interactions with external organisations. The report shows that 30% of academics actively work with private companies, and the bulk of research taking place is user-inspired or applied.

Cancer Research Technology enter into a licence agreement with international pharmaceutical company MSD to develop inhibitors of protein arginine methyltransferase 5 (PRMT5) for cancer and blood dissorder. The new drugs potentially have clinical applications in both cancer and non-cancer blood disorders.

First published on 21st January 2016 the Intellectual Property Office has proudly introduced their five year strategy.

The University of Manchester, PraxisUnico member, and Masdar Institute of Science & Technology, in Abu Dhabi launch collaborative research into graphene and 2D materials to develop desalination, energy and defence applications and various engineering applications.

PraxisUnico highlighted the role of KEC in its submission.

Investments are growing for the researchers at University of Bristol. The 'Enterprise Fund' was launched on 15th January to provide extra support for spin-outs and tax relief for individual investors who are purchase shares in those new companies.

IP Pragmatics, an IP and business development consulting firm, expands its operations in the UK with a new office in Edinburgh.

The Pioneer Award will fund research into truly innovative, ground-breaking ideas with the potential to lead to new discoveries